Literature DB >> 3826682

Is isoflurane dangerous for the patient with coronary artery disease?

L C Becker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3826682     DOI: 10.1097/00000542-198703000-00001

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  8 in total

Review 1.  Perioperative stroke. Part I: General surgery, carotid artery disease, and carotid endarterectomy.

Authors:  D H Wong
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

2.  Ventilation with isoflurane in the Triservice anaesthetic apparatus: a comparison with halothane and trichlorethylene.

Authors:  D R Roberts; R J Pethybridge
Journal:  Ann R Coll Surg Engl       Date:  1991-07       Impact factor: 1.891

3.  The influence of collateral vascularisation on haemodynamic performance during abdominal aortic surgery.

Authors:  A J Cunningham; D P O'Toole; N McDonald; F Keeling; D Bouchier-Hayes
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

Review 4.  Anaesthesia for abdominal aortic surgery--a review (Part II).

Authors:  A J Cunningham
Journal:  Can J Anaesth       Date:  1989-09       Impact factor: 5.063

5.  Influence of desflurane, isoflurane and halothane on regional tissue perfusion in dogs.

Authors:  J C Hartman; P S Pagel; L T Proctor; J P Kampine; W T Schmeling; D C Warltier
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

Review 6.  Anaesthesia for the patient with cardiac disease.

Authors:  J H Tinker
Journal:  Can J Anaesth       Date:  1988-05       Impact factor: 5.063

Review 7.  Anaesthesia for coronary artery surgery--a plea for a goal-directed approach.

Authors:  R I Hall
Journal:  Can J Anaesth       Date:  1993-12       Impact factor: 5.063

8.  Animal models and conserved processes.

Authors:  Ray Greek; Mark J Rice
Journal:  Theor Biol Med Model       Date:  2012-09-10       Impact factor: 2.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.